Five-Year Experience of Etanercept as Adjunct to Intravenous Immunoglobulin for Kawasaki Disease with Coronary Artery Involvement

Objective: The Etanercept as Adjunctive Treatment for Acute Kawasaki Disease trial was a phase 3, placebo-controlled, randomized trial that evaluated etanercept use for acute Kawasaki disease (KD). Trial data suggest improved coronary artery aneurysm metrics with etanercept compared to placebo. This...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ryan Rogers, MD, Eyal Sagiv, MD, PhD, Aaron K. Olson, MD, Michael A. Portman, MD
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-09-01
Col·lecció:	Journal of Pediatrics: Clinical Practice
Matèries:	aneurysm etanercept intensification kawasaki TNF-α vasculitis
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2950541025000274
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!